P01.10 METABOLIC CONDITIONS DETERMINE SENSITIVITY OF GLIOMA CELLS AGAINST EPIDERMAL-GROWTH FACTOR RECEPTOR (EGFR)-INHIBITION

The epidermal growth factor (EGFR) pathway is a frequently activated oncogenic pathway in glioblastoma. Nevertheless, the clinical results using EGFR inhibitors in glioma therapy are disappoiting. The reasons for the failure of these inhibitors are unclear but may involve factors of the tumor microe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hartel, I.A., Wolking, S., Wanka, C., Ronellenfitsch, M.W., Steinbach, J.P., Rieger, J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185443/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.103
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados